• Clinical Trials - Dementia

    Study Objective Contact
    A Placebo-Controlled, Double-Blinded, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-Finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects with Early Alzheimer's Disease [LCID Study Number: 2013-011] The purpose of this study is to determine if the study drug (BAN2401) is safe and effective in subjects with Mild Cognitive Impairment due to Alzheimer’s disease or mild Alzheimer’s disease Principal Investigator(s):
    Yuval Zabar, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Nicholas F. Ventura.